Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
Elissa Driggin, Parag Goyal
Topics & Concepts
MedicineIncretinGlycemicGlucagon-like peptide-1Internal medicineType 2 diabetesDiabetes mellitusGlucagon-like peptide 1 receptorEndocrinologyMalnutritionSarcopeniaAgonistReceptorDiet and metabolism studiesNutrition and Health in AgingDiabetes Treatment and Management